Product Images Lo Loestrin Fe

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Lo Loestrin Fe NDC 0430-0420 by Allergan, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

The structural formula for ethinyl estradiol is [19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17)-]. - lo loestrin fe 01

The structural formula for norethindrone acetate is [19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17)-]. - lo loestrin fe 02

Figure 1. Mean (± SD) plasma ethinyl estradiol concentration versus time profiles following single- and multiple-dose oral administration of Lo Loestrin Fe to healthy female volunteers (n = 15) - lo loestrin fe 03

Figure 2. Mean (± SD) plasma norethindrone concentration versus time profiles following single- and multiple-dose oral administration of Lo Loestrin Fe to healthy female volunteers (n = 15) - lo loestrin fe 04

The following chart shows the chance of getting pregnant for women who use different methods of birth control. Each box on the chart contains a list of birth control methods that are similar in effectiveness. The most effective methods are at the top of the chart. The box on the bottom of the chart shows the chance of getting pregnant for women who do not use birth control and are trying to get pregnant. - lo loestrin fe 05

2. Look at your pill pack: The Lo Loestrin Fe pill pack has 24 "active" blue pills (with hormones) and 2 “active” white pills (with hormones) for Weeks 1, 2, 3 and part of Week 4. The pill pack also has 2 "reminder" brown pills (without hormones) for the last part of Week 4. - lo loestrin fe 06

The text contains information about contraception methods and their effectiveness in preventing pregnancies. The vaginal ring with hormones and condoms, diaphragm, and spermicide are mentioned alongside withdrawal as methods of contraception. The text provides statistics on the number of pregnancies per 100 women in one year, with fewer than 1 pregnancy per 100 women with the vaginal ring with hormones, and 10 to 20 pregnancies per 100 women with other methods listed. However, the last sentence appears to be incomplete or unclear, possibly due to errors, and reads as "85 or more pregnancies per 100 women or pregnancies + Mobith ol." Therefore, the description based on this text is: Information about several types of contraception methods and their effectiveness in preventing pregnancies, with varying rates of success.*

PRINCIPAL DISPLAY PANELNDC 0430-0420-14Lo Loestrin Fe26 days of active therapy5 blister cards of 28 tablets eachRx Only - lo loestrin fe 07

PRINCIPAL DISPLAY PANELNDC 0430-0420-95Lo Loestrin Fe26 days of active therapy1 blister card of 28 tablets eachRx Only - lo loestrin fe 08

lo loestrin fe 09

LoLoestrn Fe is a medication that provides 26 days of active therapy. It is marketed by Allergan and is available for medical use.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.